Key result
Cellular activation commonly reflects a reciprocal pattern of regulation, namely, transcriptional induction of endothelin-1 and destabilization of the endothelial nitric oxide synthase mRNA.
Elucidating the mechanisms influencing ET-1 and eNOS mRNA provides novel insight into endothelial gene regulation and potential therapeutic strategies.
May inform endothelial-targeted research; leaves open clinical translation pending prospective validation.
Central to the control of vascular resistance in the systemic and pulmonary circulation and at the solid organ level is the function of the endothelial-derived vasomediators, endothelin-1 (ET-1) and nitric oxide. Regulation of steady-state levels of ET-1 and endothelial nitric oxide synthase (eNOS) mRNAs represents an early and influential step in their biosynthesis and is highly responsive to exogenous stimuli. ET-1 is expressed from a rapidly inducible promoter to generate a highly labile mRNA. Conversely, the eNOS promoter generates a constitutive level of a very stable mRNA and utilizes posttranscriptional mechanisms to modulate mRNA expression. The response of these genes in models of cellular activation commonly reflects a reciprocal pattern of regulation, namely, transcriptional induction of ET-1 and destabilization of the eNOS mRNA. Elucidating the mechanisms influencing ET-1 and eNOS mRNA is providing novel insight into endothelial gene regulation and providing opportunities for future therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Mawji et al. (2002) conducted a review in Vascular resistance regulation. Cellular activation commonly reflects a reciprocal pattern of regulation, namely, transcriptional induction of endothelin-1 and destabilization of the endothelial nitric oxide synthase mRNA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: